The Pharma Data
OCTOBER 16, 2020
As pharma companies search for solutions to avoid cancelling or delaying clinical trials, virtualizing trials are fast becoming commonplace during the Covid-19 pandemic. In vitro antiviral technology proves effective against SARS-CoV-2 in human airway infection model.
pharmaphorum
FEBRUARY 13, 2022
Quris’ BioAI safety prediction platform – which is based on human tissue samples on chips, nanosensors and machine learning – will be compared to traditional in vitro and in vivo laboratory techniques for spotting toxicity. The post Merck will assess Quris’ AI ‘patient-on-a-chip’ drug safety appeared first on.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
DECEMBER 1, 2022
Exploring the implementation of complex in-vitro models for drug development. The pharmaceutical industry globally is realising the growing potential of in vitro tissue models for drug discovery, pathology modelling and validation, safety and toxicity. Billion by 2028. Billion by 2028. Event Hashtag: #3DCellCulture2023.
pharmaphorum
JANUARY 18, 2022
Developing Complex, Translatable and Physiologically-Relevant Cellular Models in vitro. Key Benefits of Attending: • Discuss the uses of advanced cell technologies to construct in vitro models of human tissues. Uncover the major benefits of 3D modelling in enhancing clinical translation and predictability. Who Should Attend?
pharmaphorum
OCTOBER 12, 2020
Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers for in vitro applications patient-derived tissues, drug discovery, predictivity and validation, and safety and toxicity. 3D-cellculture.com/PR1. . 3D-cellculture.com/PR1. 3D Cell Culture 2020.
pharmaphorum
OCTOBER 18, 2021
There was a genuine sense of alliance; regulatory bodies and pharma companies coming together to accelerate processes and find the most optimal model for collaboration. Also worth exploring is the regulatory oversight and approval process for medical devices and in-vitro diagnostics (IVDs). And there are many.
pharmaphorum
DECEMBER 16, 2020
We had companies collaborating to develop laboratories. We had companies sourcing consumables for testing machines. There were companies that allowed their staff to volunteer to deliver medicines to vulnerable people, and many HCPs that work in the industry have gone back to frontline care. Strength in the second wave.
Expert insights. Personalized for you.
52 
Let's personalize your content